25-Hydroxyvitamin D concentrations in COVID-19 patients hospitalized in intensive care unit during the first wave and the second wave of the pandemic

Clin Chem Lab Med. 2021 Mar 3;59(6):e255-e258. doi: 10.1515/cclm-2021-0207. Print 2021 May 26.

Antonin Saldmann^{1

2}, Annabelle Stoclin³, Sophie Rym Hamada^{2

4}, Bernard Cholley^{2

4}, Pascal Houillier^{2

5}, Stéphanie Baron^{2

5}, Caroline Prot-Bertoye^{2

5}, Simon Travers^{2

5}, Gérard Friedlander^{2

5}, Anne-Sophie Jannot^{2

6}, Jean-Claude Souberbielle⁷, Marie Courbebaisse^{2

5}

¹ Immunology Department, European Georges Pompidou Hospital, APHP, Paris, France.
² University of Paris, Paris, France.
³ Intensive Care Unit, Interdisciplinary Cancer Course Department (DIOPP), Villejuif, France.
⁴ Department of Anesthesia and Critical Care, European Georges Pompidou Hospital, APHP, Paris, France.
⁵ Physiology Department, European Georges Pompidou Hospital, APHP, Paris, France.
⁶ Medical Informatics, Biostatistics and Public Health Department, European Georges Pompidou Hospital, APHP, Paris, France.
⁷ Physiology Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France.

No abstract available

Keywords: COVID-19; intensive care unit; vitamin D.

Publication types